Multiple Rising Dose Study of MK-6194 in Participants With Atopic Dermatitis (MK-6194-008)

Clinical trial NCT05450198 · COMPLETED

Trial details

NCT number: NCT05450198
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Dermatitis, Atopic

Start date: 2022-08-08
Primary completion: 2024-05-22
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.